The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-4015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study ; volume:5 ; number:1 ; day:16 ; month:3 ; year:2016 ; pages:1-6 ; date:12.2016
Israel Journal of Health Policy Research ; 5, Heft 1 (16.3.2016), 1-6, 12.2016
- Creator
-
Frankenthal, Dvora
- Contributor
-
Zandman-Goddard, Gisele
Ben-Muvhar, Yael
Porat-Katz, Bat Sheva
SpringerLink (Online service)
- DOI
-
10.1186/s13584-016-0070-y
- URN
-
urn:nbn:de:1111-201603171905
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frankenthal, Dvora
- Zandman-Goddard, Gisele
- Ben-Muvhar, Yael
- Porat-Katz, Bat Sheva
- SpringerLink (Online service)
Other Objects (12)
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Intraoperative low tidal volume ventilation and the risk of ICD-10 coded delirium and the use for antipsychotic medications
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Intraoperative low tidal volume ventilation and the risk of ICD-10 coded delirium and the use for antipsychotic medications
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia